Resultats de la cerca - Agusti, Alvar

Fibrinogen and COPD: Now what? per Faner, Rosa, Agusti, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

Natural history of COPD: gaps and opportunities per Agustí, Alvar, Celli, Bartolomé

Obtenir text complet Obtenir text complet Obtenir text complet

Chronic obstructive pulmonary disease at the beginning of the XXI Century per Agusti, Alvar, Zhang, Jing

Obtenir text complet Obtenir text complet Obtenir text complet

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease per Agusti, Alvar, Faner, Rosa

Obtenir text complet Obtenir text complet Obtenir text complet

COPD: time to improve its taxonomy? per Celli, Bartolomé R., Agustí, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

GOLD 2024: a brief overview of key changes per Agusti, Alvar, Vogelmeier, Claus F.

Obtenir text complet

Lack of Bacterial Colonization Measure in Randomized Controlled Trial on Inhaled Corticosteroids Effect in Patients with Chronic Obstructive Pulmonary Disease per Martinez-Garcia, Miguel Angel, Agustí, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 per Agusti, Alvar, Torres, Ferran, Faner, Rosa

Obtenir text complet Obtenir text complet Obtenir text complet

Highlights and hot topics in the management of COPD: where are we heading? per Agustí, Alvar, Jones, Paul W, Vogelmeier, Claus

Obtenir text complet Obtenir text complet Obtenir text complet

Are women with asthma at increased risk for severe COVID-19? per Fernando, Mario, Agusti, Alvar, Dharmage, Shyamali, Lodge, Caroline

Obtenir text complet Obtenir text complet Obtenir text complet

COVID-19 and COPD: lessons beyond the pandemic per Halpin, David M. G., Vogelmeier, Claus F., Agusti, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study per Adir, Yochai, Hakrush, Omar, Shteinberg, Michal, Schneer, Sonia, Agusti, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

COPD & COVID-19 per Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.

Obtenir text complet Obtenir text complet Obtenir text complet

COPD & COVID-19 per Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.

Obtenir text complet Obtenir text complet Obtenir text complet

Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications per Agusti, Alvar, Fabbri, Leonardo, Lahousse, Lies, Singh, Dave, Papi, Alberto

Obtenir text complet Obtenir text complet Obtenir text complet

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect per Faner, Rosa, Gonzalez, Nuria, Cruz, Tamara, Kalko, Susana Graciela, Agustí, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

Current concepts in targeting COPD pharmacotherapy: making progress towards personalized management per Woodruff, Prescott G., Agusti, Alvar, Roche, Nicolas, Singh, Dave, Martinez, Fernando J.

Obtenir text complet Obtenir text complet Obtenir text complet

Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns per Agustí, Alvar, Calverley, Peter M., Decramer, Marc, Stockley, Robert A., Wedzicha, Jadwiga A.

Obtenir text complet Obtenir text complet Obtenir text complet

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? per Halpin, David M G, Faner, Rosa, Sibila, Oriol, Badia, Joan Ramon, Agusti, Alvar

Obtenir text complet Obtenir text complet Obtenir text complet

Cellular Senescence in Lung Fibrosis per Hernandez-Gonzalez, Fernanda, Faner, Rosa, Rojas, Mauricio, Agustí, Alvar, Serrano, Manuel, Sellarés, Jacobo

Obtenir text complet Obtenir text complet Obtenir text complet